| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1031799033 |
| P356 | DOI | 10.1023/A:1022106910017 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1023/a:1022106910017 |
| P698 | PubMed publication ID | 12622454 |
| P2093 | author name string | Roger Henriksson | |
| Urban Ungerstedt | |||
| A Tommy Bergenheim | |||
| Per Bergström | |||
| Michael Roslin | |||
| P2860 | cites work | The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. | Q34062645 |
| Functional correlates of dopamine neurotransmission | Q34208043 | ||
| Interstitial fluid pressure in intracranial tumours in patients and in rodents | Q36116465 | ||
| Interstitial glycerol as a marker for membrane phospholipid degradation in the acutely injured human brain | Q36318114 | ||
| Metabolism of the malignant astrocytoma | Q38137664 | ||
| In vivo study of tumor metabolism: an application of new multi-probe microdialysis system in the striatum of freely moving rats grafted with C6 cells | Q40848227 | ||
| Cerebral microdialysis as a diagnostic tool in acute brain injury | Q41061267 | ||
| Regulation of glutamate in cultures of human monocytic THP-1 and astrocytoma U-373 MG cells | Q41086360 | ||
| Cerebral microdialysis combined with single-neuron and electroencephalographic recording in neurosurgical patients. Technical note | Q41693615 | ||
| Intracerebral microdialysis and bedside biochemical analysis in patients with fatal traumatic brain lesions | Q43750104 | ||
| Glucose gradient differences in subcutaneous tissue of healthy volunteers assessed with ultraslow microdialysis and a nanolitre glucose sensor | Q44098583 | ||
| Respiratory patterns in human brain tumors | Q44821353 | ||
| An adapter for computed tomography-guided stereotaxis. | Q48484376 | ||
| Chemical monitoring of neurosurgical intensive care patients using intracerebral microdialysis. | Q48555735 | ||
| In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas. | Q48710063 | ||
| Glycerol as a marker for post-traumatic membrane phospholipid degradation in rat brain. | Q48728530 | ||
| A comparative study on ventriculographic and computerized tomography-guided determinations of brain targets in functional stereotaxis. | Q48888691 | ||
| Neurochemical monitoring using intracerebral microdialysis in patients with subarachnoid hemorrhage. | Q49046660 | ||
| Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma. | Q49086231 | ||
| Intracerebral microdialysis in clinical practice: baseline values for chemical markers during wakefulness, anesthesia, and neurosurgery. | Q51381293 | ||
| Percutaneous stereotactic brain tumour biopsy and cyst aspiration with a non-invasive frame. | Q51742662 | ||
| Extracellular glutamate and other metabolites in and around RG2 rat glioma: an intracerebral microdialysis study. | Q55475337 | ||
| The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine. | Q55478784 | ||
| Uptake of glutamate and cysteine in C-6 glioma cells and in cultured astrocytes. | Q55484344 | ||
| The role of excitatory amino acids and NMDA receptors in traumatic brain injury | Q69370501 | ||
| Cerebral microdialysis monitoring: determination of normal and ischemic cerebral metabolisms in patients with aneurysmal subarachnoid hemorrhage | Q73143939 | ||
| Microdialysis--a new technique for monitoring local tissue events in the clinic | Q73567440 | ||
| Clinical cerebral microdialysis: a methodological study | Q73962914 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 151-160 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
| P1476 | title | Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis | |
| P478 | volume | 61 |
| Q79434798 | A bioluminescence technique for quantitative and structure-associated imaging of pyruvate |
| Q46620529 | A possible mechanism for the beneficial effect of ethanol in essential tremor |
| Q36917114 | A role for glutamate in growth and invasion of primary brain tumors |
| Q61800472 | AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro |
| Q36316592 | Advances in gas chromatographic methods for the identification of biomarkers in cancer. |
| Q39504516 | Autophagy in hypoxia protects cancer cells against apoptosis induced by nutrient deprivation through a Beclin1-dependent way in hepatocellular carcinoma |
| Q42319474 | Biochemical changes in the injured brain |
| Q83381161 | Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas |
| Q39384950 | Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas |
| Q35489076 | Brain energy metabolism and intracranial pressure in idiopathic adult hydrocephalus syndrome. |
| Q39148077 | Caloric restriction reduces edema and prolongs survival in a mouse glioma model |
| Q39817583 | Characterization of the serum metabolome following radiation treatment in patients with high-grade gliomas |
| Q37847259 | Clinical microdialysis in neuro-oncology: principles and applications |
| Q35535883 | Cortical GABAergic excitation contributes to epileptic activities around human glioma. |
| Q33972116 | Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy |
| Q45286242 | Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study |
| Q33778107 | ERGO: a pilot study of ketogenic diet in recurrent glioblastoma |
| Q35067815 | Efficacy of local polymer-based and systemic delivery of the anti-glutamatergic agents riluzole and memantine in rat glioma models |
| Q48785054 | Elevated basal glutamate and unchanged glutamine and GABA in refractory epilepsy: Microdialysis study of 79 patients at the yale epilepsy surgery program. |
| Q37892605 | Excitatory action of GABA on immature neurons is not due to absence of ketone bodies metabolites or other energy substrates |
| Q37984474 | Exploiting metabolic differences in glioma therapy |
| Q27320014 | Fasting enhances the response of glioma to chemo- and radiotherapy |
| Q40869992 | Ganciclovir concentrations in the cerebral extracellular space after valganciclovir treatment; a case study |
| Q46532765 | Glucose metabolites, glutamate and glycerol in malignant glioma tumours during radiotherapy |
| Q37824652 | Glutamate and the biology of gliomas |
| Q27011499 | Glutamate and tumor-associated epilepsy: glial cell dysfunction in the peritumoral environment |
| Q39765238 | Glutamate promotes cell growth by EGFR signaling on U-87MG human glioblastoma cell line. |
| Q39141123 | Human astrocytes in the diseased brain. |
| Q36162265 | Human glioma cells induce hyperexcitability in cortical networks |
| Q48733867 | IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low-grade gliomas. |
| Q41541275 | Immunoexcitatory mechanisms in glioma proliferation, invasion and occasional metastasis |
| Q43284404 | In vivo assessment of high-grade glioma biochemistry using microdialysis: a study of energy-related molecules, growth factors and cytokines |
| Q39148987 | Increased glutamate uptake in astrocytes via propentofylline results in increased tumor cell apoptosis using the CNS-1 glioma model |
| Q37189377 | Inhibition of cystine uptake disrupts the growth of primary brain tumors |
| Q64971099 | Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: a feasibility and safety study. |
| Q40006082 | Knockdown of GluR1 expression by RNA interference inhibits glioma proliferation |
| Q47235908 | Low-carbohydrate diet versus caloric restriction: effects on weight loss, hormones, and colon tumor growth in obese mice |
| Q48497505 | Metabolic manipulation of glioblastoma in vivo by retrograde microdialysis of L-2, 4 diaminobutyric acid (DAB). |
| Q28286868 | Metabolic remodeling of malignant gliomas for enhanced sensitization during radiotherapy: an in vitro study |
| Q91826271 | Metabolic response patterns in brain microdialysis fluids and serum during interstitial cisplatin treatment of high-grade glioma |
| Q60930189 | Mitochondrial Substrate-Level Phosphorylation as Energy Source for Glioblastoma: Review and Hypothesis |
| Q37601178 | Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity |
| Q101038548 | Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression |
| Q34460630 | Overexpression of calcium-permeable glutamate receptors in glioblastoma derived brain tumor initiating cells |
| Q48489738 | Perioperative microdialysis in meningioma surgery: correlation of cerebral metabolites with clinical outcome. |
| Q47419145 | Peritumoural glutamate correlates with post-operative seizures in supratentorial gliomas. |
| Q41820198 | Radiotherapy induces an immediate inflammatory reaction in malignant glioma: a clinical microdialysis study |
| Q35652218 | Review of microdialysis in brain tumors, from concept to application: first annual Carolyn Frye-Halloran symposium |
| Q34542313 | Role of glucose and ketone bodies in the metabolic control of experimental brain cancer |
| Q34543666 | Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor-kappaB. |
| Q89510879 | Targeting Glutamine Addiction in Gliomas |
| Q24537119 | Targeting energy metabolism in brain cancer: review and hypothesis |
| Q47886328 | Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma |
| Q37628732 | The anti-oxidant capacity of tumour glycolysis |
| Q34013084 | The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implications for the current approach to chemoradiation |
| Q37736329 | The role of mitochondria in glioma pathophysiology |
| Q34293667 | Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasis |
| Q38589482 | Translational potential of astrocytes in brain disorders |
| Q42825367 | [2,4-(13)C]β-hydroxybutyrate metabolism in astrocytes and C6 glioblastoma cells |
Search more.